ReviewFrontiers in immunology2022

Targeting inflammation and immune activation to improve CTLA4-Ig-based modulation of transplant rejection.

Marcos Iglesias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.